adjust est loxo
lower ep
expect lower guidanc rang
compani report result wed feb
chang explain lower revenu
ep per share reduct includ
estimate share hit lartruvo consist guidanc estimate
impact plan acquisit loxo lower lartruvo revenue
 beyond due failur phase
studi sarcoma jeopard acceler approv ad vitrakvi
model start plu spend
major pharmaceut unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
base case ep premium peer
median due lilli better growth prospect ep
bull case ep
bull case ep
new product drive revenu upsid oper leverag boost ep
forecast price-to-earnings multipl expand strong execut repres
potenti addit upsid beyond bull case
base case ep
base case ep
see solid growth prospect balanc premium valuat new product
launch meet slightli exceed expect pipelin progress continu
bear case ep
bear case ep
us revenu growth disappoint drive earn expect pipelin
disappoint occur investor becom concern competit
threat key franchis multipl contract due lower growth expect
enthusiasm new product momentum
balanc premium valuat
project consist revenu growth
margin expans drive durabl ep
transact enhanc long-term growth
quarterli result financi guidanc
verzenio trulic jardianc taltz
result
pipelin news flow includ
outcom studi detail ada jun
extern busi develop
risk achiev price
upsid risk posit financi result
project new product revenu
forecast financi result upsid
product disappoint compel extern
downsid risk financi result fall
short expect face us
compet drug surpris upsid
exhibit new vs old consensu estim
valuat methodolog risk associ price target rate recommend referenc research report pleas contact client support follow us/canada hong kong
latin america london singapor sydney tokyo altern may contact invest repres
morgan stanley research broadway attent research manag new york ny usa
price
price
price
price data
price data
sg sale
 sale
short-term invest
a/p accru liabil
total liabil s/e
chang work capit
oper
invest
net chang debt
financ
net chang cash
